Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143732 |
| CAS No | NA |
| Mol.F. | C9H9D3N2O3 |
| Mol.Wt. | 199.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143733 |
| CAS No | NA |
| Mol.F. | C24H31FN4O3 |
| Mol.Wt. | 442.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143734 |
| CAS No | NA |
| Mol.F. | C16H18N2O5 |
| Mol.Wt. | 318.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143735 |
| CAS No | NA |
| Mol.F. | C19H34N2O |
| Mol.Wt. | 306.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143736 |
| CAS No | NA |
| Mol.F. | C19H20N2O |
| Mol.Wt. | 292.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143737 |
| CAS No | 68897-50-7 |
| Mol.F. | C13H18N4O5 |
| Mol.Wt. | 310.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143738 |
| CAS No | NA |
| Mol.F. | C10H11D3N2O2 |
| Mol.Wt. | 197.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143739 |
| CAS No | NA |
| Mol.F. | C18H18N2OS |
| Mol.Wt. | 310.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143740 |
| CAS No | NA |
| Mol.F. | C29H31ClN6O3 |
| Mol.Wt. | 547.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143741 |
| CAS No | NA |
| Mol.F. | C13H10ClN3O4 : Li |
| Mol.Wt. | 307.7 : 6.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143742 |
| CAS No | 75881-20-8 |
| Mol.F. | C15H32N2O |
| Mol.Wt. | 256.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143743 |
| CAS No | 55556-85-9 |
| Mol.F. | C5H10N2O2 |
| Mol.Wt. | 130.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143744 |
| CAS No | 2308465-20-3 |
| Mol.F. | C5H8N2O4 |
| Mol.Wt. | 160.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143745 |
| CAS No | 56654-52-5 |
| Mol.F. | C9H19N3O2 |
| Mol.Wt. | 201.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143746 |
| CAS No | 614-95-9 |
| Mol.F. | C5H10N2O3 |
| Mol.Wt. | 146.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143746 |
| CAS No | 614-95-9 |
| Mol.F. | C5H10N2O3 |
| Mol.Wt. | 146.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |